Wilking N - Search Results

1

Receptors for estrogen and progesterone in breast carcinoma in situ.

Pallis L, Wilking N, Cedermark B, Rutqvist LE, Skoog L. Pallis L, et al. Among authors: wilking n. Anticancer Res. 1992 Nov-Dec;12(6B):2113-5. Anticancer Res. 1992. PMID: 1295456

2

The DNA profile of breast cancer in situ.

Pallis L, Skoog L, Falkmer U, Wilking N, Rutquist LE, Auer G, Cedermark B. Pallis L, et al. Among authors: wilking n. Eur J Surg Oncol. 1992 Apr;18(2):108-11. Eur J Surg Oncol. 1992. PMID: 1582502

3

Analysis of hormone receptors and proliferation fraction in fine-needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen treatment.

Skoog L, Rutqvist LE, Wilking N. Skoog L, et al. Among authors: wilking n. Acta Oncol. 1992;31(2):139-41. doi: 10.3109/02841869209088893. Acta Oncol. 1992. PMID: 1622628

4

Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Stockholm Breast Cancer Study Group.

Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, Skoog L, Somell A, Theve T, Wilking N, Askergren J, et al. Rutqvist LE, et al. Among authors: wilking n. Acta Oncol. 1992;31(2):265-70. doi: 10.3109/02841869209088913. Acta Oncol. 1992. PMID: 1622644 Clinical Trial.

5

Immunocytochemical analysis of receptors for estrogen and progesterone in fine needle aspirates from anal epidermoid carcinoma.

Goldman S, Skoog L, Wilking N. Goldman S, et al. Among authors: wilking n. Dis Colon Rectum. 1992 Feb;35(2):163-5. doi: 10.1007/BF02050672. Dis Colon Rectum. 1992. PMID: 1735318

6

Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.

Rutqvist LE, Cedermark B, Glas U, Mattsson A, Skoog L, Somell A, Theve T, Wilking N, Askergren J, Hjalmar ML, et al. Rutqvist LE, et al. Among authors: wilking n. J Natl Cancer Inst. 1991 Sep 18;83(18):1299-306. doi: 10.1093/jnci/83.18.1299. J Natl Cancer Inst. 1991. PMID: 1886157 Clinical Trial.

7

Steroid receptor levels in breast cancer. Relationships with age and menopausal status.

Wilking N, Rutqvist LE, Nordenskjöld B, Skoog L. Wilking N, et al. Acta Oncol. 1989;28(6):807-10. doi: 10.3109/02841868909092312. Acta Oncol. 1989. PMID: 2611034

8

Lack of correlation between anxiety parameters and oestrogen receptor status in early breast cancer.

Rosenqvist S, Berglund G, Bolund C, Fornander T, Rutqvist LE, Skoog L, Wilking N. Rosenqvist S, et al. Among authors: wilking n. Eur J Cancer. 1993;29A(9):1325-6. doi: 10.1016/0959-8049(93)90083-r. Eur J Cancer. 1993. PMID: 8343278

9

Subcutaneous metastasis from an ovarian carcinoma disappeared following tamoxifen therapy.

Flam F, Skoog L, Wilking N. Flam F, et al. Among authors: wilking n. Eur J Obstet Gynecol Reprod Biol. 1996 Feb;64(2):225-6. doi: 10.1016/0301-2115(95)02281-3. Eur J Obstet Gynecol Reprod Biol. 1996. PMID: 8820008

10

Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group.

Wilking N, Rutqvist LE, Carstensen J, Mattsson A, Skoog L. Wilking N, et al. Acta Oncol. 1992;31(1):29-35. doi: 10.3109/02841869209088261. Acta Oncol. 1992. PMID: 1586501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters